Market News
Global Chitosan Market: Recent Development
- In April 2020, MaxioCel, a chitosan-based next-generation wound care dressing, was introduced by Axio Biosolutions. Patients with chronic injuries such as venous leg ulcers, diabetic foot ulcers, post-operative surgical wounds, pressure ulcers, skin abrasions, cavity wounds, and donor sites may benefit from the "first of its type" solution, which is supposed to give relief and speed recovery. With its integrated scar healing, hemostatic, and pain management properties, MaxioCel fills a significant market gap.
- In May 2021, Friesland foods Kievit a prominent player who has created this novel encapsulating technology to promote the usage of chitosan as a natural product. By establishing a distinct business organization, Kievit Ventures, Friesland Foods Kievit claims to have accelerated long-term innovation in encapsulation technology. Manufacturers are also focusing on the expansion of manufacturing facilities globally to maintain their global presence.
- In March 2021, in Brazil, the University of Brasilia, in collaboration with the University of Campinas, Brazil, Centro de Pesquisa em Biotecnologia Ltda, Hospital Regional da Asa Norte (HRAN), Hospital da Região Leste (HRL), and Hospital Universitário de Brasília (HUB/UnB), was conducting VESTA clinical trial to assess the effectiveness of a novel respirator with chitosan nanoparticles to reduce the incidence of SARS-CoV-2 infection in healthcare professionals.
- In March 2020, Bioavanta-Bosti, a leader in chitosan nanoparticles research, launched Novochizol, which is a unique chitosan nanoparticle technology that can be used to deliver and confine any potential anti-COVID-19 drug to the lungs of acutely ill patients.
U.S.: 
U.K. : 
India : 
